Neurosense Therapeutics Ltd share price logo

Neurosense Therapeutics Ltd Share Price

NASDAQ: NRSN

Small Cap

$1.18

+0.01

(+1.20%)

as on

Neurosense Therapeutics Ltd Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.12
    $1.2
    downward going graph

    5.08%

    Downside

    1.69%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.8
    $2.6
    downward going graph

    32.20%

    Downside

    120.34%

    Upside

    downward going graph

Neurosense Therapeutics Ltd share price movements today

Previous Close
$1.17
Open
$1.12
Volume
343.7K
Day's Low - High
$1.12 - $1.2
52 Week Low - High
$0.8 - $2.6

Neurosense Therapeutics Ltd Historical Returns

1 Month Return
-6.4 %
3 Month Return
-52.24 %
1 Year Return
-13.33 %
3 Year Return
-40.61 %
5 Year Return
0 %

Neurosense Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Neurosense Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.6M

EPS (TTM)

-0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-8.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

357700.00%

Neurosense Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neurosense Therapeutics Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$29.6MNANA0.00%
BUY$60.5B248.74%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Neurosense Therapeutics Ltd Stock including INR - Dollar returns

The Neurosense Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Neurosense Therapeutics Ltd investment value today

Current value as on today

₹92,006

Returns

₹7,994

(-7.99%)

Returns from Neurosense Therapeutics Ltd Stock

₹12,593 (-12.59%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Neurosense Therapeutics Ltd Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Neurosense Therapeutics Ltd. Average target price of $14

Neurosense Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Neurosense Therapeutics Ltd.

What analysts predicted

91.57%UPSIDE

Target Price

$14

Current Price

$1.18

Analyzed by

8 Analysts

Target

$14.00

Neurosense Therapeutics Ltd target price $14, a slight upside of 91.57% compared to current price of $1.18. According to 8 analysts rating.

Neurosense Therapeutics Ltd Stock's Interest Amongst Investors

Search interest for Neurosense Therapeutics Ltd Stock has increased by 311% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:311% versus previous 30 day period

Neurosense Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
Operating Income
-3
-2
-3
-2
-3
-2
-3
-2
-1
EBITDA
-3
-2
-5
0
-
-2
-3
-2
-
Interest Expense
0
0
1
0
2
2
2
0
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-3
-3
-2
0
-2
-5
0
-2
-1
Income Tax Expense
0
0
-2
5
-
0
-
-
-
Net Income
-3
-2
-5
0
-2
-5
0
-2
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Neurosense Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
Operating Income
-1
-2
-5
-13
-12
-9
EBITDA
-1
-2
-2
-13
-9
-9
Interest Expense
0
0
1
0
0
0
Depreciation
-
0
0
0
0
0
Income Before Tax
-1
-2
-4
-12
-11
-10
Income Tax Expense
0
0
-1
-1
0
-
Net Income
-1
-2
-2
-10
-10
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Neurosense Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
0
0
0
-2
0
0
0
-1
0
Operating Cash Flow
-
0
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
Change in Cash
-2
5
-2
-
-
-
-
-
-

Neurosense Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-4
-12
-10
-10
Operating Cash Flow
0
-1
-7
-8
-10
Investing Cash Flow
0
0
-3
3
0
Financing Cash Flow
0
11
3
3
10
Change in Cash
0
10
-7
0
0

Global Institutional Holdings in Neurosense Therapeutics Ltd

Funds
Holdings
Morgan Stanley - Brokerage Accounts
0.21%
Meitav Dash Investments Ltd
0.17%
XTX Topco Ltd
0.14%
Commonwealth Equity Services Inc
0.07%
Geode Capital Management, LLC
0.07%

Insights on Neurosense Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 151.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 81.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NRSN stock has moved down by -51.8%

About Neurosense Therapeutics Ltd

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa
OrganisationNeurosense Therapeutics Ltd
HeadquartersBuilding B, Herzliya, Israel, 4672562
CEOMr. Alon Ben-Noon
E-voting on sharesClick here to vote

Key Management of Neurosense Therapeutics Ltd

Name

Title

Mr. Eidan Loushi

Lead C.R.A.

Mr. Alon Ben-Noon

Co-Founder, CEO & Director

Mr. Or Eisenberg

Chief Financial Officer

Dr. Niva Russek-Blum Ph.D.

Chief Technology Officer

Dr. Ferenc Tracik M.D.

Chief Medical Officer

Ms. Yael Barak

VP of Quality & Compliance

Ms. Keren Pushett

Head of HR

FAQs

What is Neurosense Therapeutics Ltd share price today?

Neurosense Therapeutics Ltd share price today is $1.18 as on at the close of the market. Neurosense Therapeutics Ltd share today touched a day high of $1.2 and a low of $1.12.

What is the 52 week high and 52 week low for Neurosense Therapeutics Ltd share?

Neurosense Therapeutics Ltd share touched a 52 week high of $2.6 on and a 52 week low of $0.8 on . Neurosense Therapeutics Ltd stock price today i.e. is closed at $1.18,which is 54.62% down from its 52 week high and 47.50% up from its 52 week low.

What is Neurosense Therapeutics Ltd's market capitalisation today?

Neurosense Therapeutics Ltd market capitalisation is $0.00T as on .

How to invest in Neurosense Therapeutics Ltd Stock (NRSN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neurosense Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurosense Therapeutics Ltd Shares that will get you 1.2712 shares as per Neurosense Therapeutics Ltd share price of $1.18 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Neurosense Therapeutics Ltd Stock (NRSN) from India?

Indian investors can start investing in Neurosense Therapeutics Ltd (NRSN) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Neurosense Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Neurosense Therapeutics Ltd share’s latest price of $1.18 as on September 18, 2025 at 1:29 am IST, you will get 8.4746 shares of Neurosense Therapeutics Ltd. Learn more about fractional shares .